Nephros (STU:NPJP) Beta: N/A (As of Jul. 07, 2026)


STU:NPJP Nephros Inc STU:NPJP
46 GF Score
Price €2.96
GF Value €2.40
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Nephros Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-07), Nephros's Beta is Not available.

Nephros  (STU:NPJP) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Nephros Beta Related Terms

Nephros Beta Historical Data

* Premium members only.

The historical data trend for Nephros's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nephros Beta Chart

Nephros Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nephros Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:NPJP
46GF Score
Nephros Inc STU:NPJP
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nephros Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Nephros (STU:NPJP) Overvalued in 2026?

Based on GuruFocus' analysis, Nephros stock appears to be overvalued. The current stock price of €2.96 is trading 23.3% above its estimated GF Value™ of €2.40. GuruFocus considers Nephros to be Modestly Overvalued.

Key valuation signals for STU:NPJP:

  • Beta: N/A
  • GF Value™: €2.40 vs. price of €2.96 (23.3% above fair value)
  • GF Score™: 46/100 with 5 warning signs

No single metric tells the full story. See the STU:NPJP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nephros Business Description

Other Exchanges NEPH:USA
Address 380 Lackawanna Place, South Orange, NJ, USA, 07079
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
46GF Score

Get the complete analysis for STU:NPJP

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.96
Price
€2.40
GF Value